Metformin: Benefits, Side Effects, Kidney Safety, and What Patients Should Know

Metformin is one of the most widely prescribed medications for type 2 diabetes. It has been used for decades to help control blood sugar, is generally affordable, and has a long history of clinical use.

Despite its established role in diabetes treatment, metformin is sometimes surrounded by misleading claims online. Some posts suggest that it damages the kidneys, causes dangerous acid buildup in the blood, or seriously disrupts gut health. Others describe it as an almost risk-free medication that everyone with insulin resistance should take.

Neither description tells the whole story.

Metformin is an effective medication for many people, but it has potential side effects and important prescribing precautions. Kidney function, other medical conditions, vitamin B12 levels, and individual treatment goals all matter when deciding whether it is appropriate.

Understanding how the medicine works—and separating genuine risks from common misconceptions—can help patients have more informed conversations with their healthcare providers.

How Does Metformin Work?

Metformin belongs to a class of medicines called biguanides. Its main role in type 2 diabetes treatment is to reduce the amount of glucose released by the liver and improve the body’s response to insulin.

The liver naturally produces glucose, including between meals and overnight. In people with type 2 diabetes, this glucose production may be excessive, contributing to elevated blood sugar levels.

Metformin helps address this problem by reducing hepatic glucose production. It also improves insulin sensitivity, allowing the body to use insulin more effectively.

Researchers have investigated several cellular mechanisms behind these effects, including changes in mitochondrial energy metabolism and the activity of AMP-activated protein kinase (AMPK). However, metformin’s full mechanism of action is complex and is not explained by a single pathway.

Why metformin is different from some other diabetes medicines

Some diabetes medications stimulate the pancreas to release more insulin. Metformin works differently: it does not directly force insulin secretion.

As a result, metformin used alone generally has a low risk of causing hypoglycemia, or dangerously low blood sugar. The risk can increase when it is combined with insulin or certain other diabetes medications.

Metformin is also generally weight-neutral or may produce modest weight loss in some people. It does not typically cause the weight gain associated with certain other diabetes treatments.

Does Metformin Damage the Kidneys?

One of the most common concerns about metformin is whether it can cause kidney damage.

Metformin is not generally considered a kidney-damaging medication. The important issue is that the kidneys remove metformin from the body. When kidney function becomes significantly impaired, the medicine can accumulate, increasing the risk of a rare but serious complication called lactic acidosis.

This distinction matters: reduced kidney function can make metformin unsafe, but that does not mean metformin itself routinely causes kidney disease.

When does kidney function become a concern?

Doctors assess kidney function using a blood test that helps estimate the glomerular filtration rate (eGFR).

General prescribing guidance includes:

• eGFR of 45 or higher: Metformin can generally be used, depending on the patient’s overall health and other prescribing considerations.
• eGFR between 30 and 44: Starting metformin is generally not recommended. If someone is already taking it, the clinician may reassess the benefits, risks, and dose.
• eGFR below 30: Metformin is contraindicated and should be discontinued under medical supervision.

Kidney function should be checked before treatment and monitored periodically, particularly in older adults and people with existing kidney disease.

Patients should not adjust or stop their medication based on an eGFR result without speaking to their healthcare professional.

How Serious Is the Risk of Lactic Acidosis?

Lactic acidosis is a rare but potentially life-threatening condition in which lactic acid builds up in the bloodstream, making the blood too acidic.

Metformin-associated lactic acidosis is uncommon, but the risk becomes more concerning when the medicine accumulates or when a person develops a serious illness that affects oxygen delivery, circulation, or organ function.

Examples of situations requiring particular caution include:

• Severe kidney impairment
• Serious infections or sepsis
• Severe dehydration
• Shock or significant circulatory problems
• Certain episodes of acute heart or respiratory failure
• Conditions involving significant oxygen deprivation

The history of lactic acidosis associated with an older diabetes drug called phenformin is sometimes used to explain concerns about metformin. Phenformin was withdrawn because of its unacceptable safety risks. Metformin has a different safety profile, although its own risk precautions remain important.

When should patients seek urgent medical help?

Unusual severe weakness, muscle pain, breathing difficulties, abdominal discomfort, or feeling unusually cold can occur in serious illness and require prompt medical assessment, particularly in someone taking metformin.

These symptoms do not automatically mean lactic acidosis, but they should not be ignored.

Common Metformin Side Effects

Although metformin is generally well tolerated, digestive problems are among its most frequently reported side effects.

Some people experience symptoms when they first start treatment or after their dose is increased.

Common effects include:

• Diarrhea or loose stools
• Nausea
• Abdominal discomfort
• Bloating
• Gas
• A metallic taste in the mouth

For many people, these symptoms improve as the body adjusts. Others may continue to experience discomfort and need their treatment reviewed.

How can gastrointestinal side effects be managed?

Doctors often recommend starting with a low dose and increasing it gradually, depending on blood sugar control and tolerance.

Taking metformin with food may also help reduce stomach discomfort.

For some patients, an extended-release (ER or XR) formulation may be easier to tolerate than immediate-release metformin. However, it does not eliminate digestive side effects in everyone.

If symptoms are persistent or severe, patients should discuss them with their healthcare provider rather than changing the dose themselves.

The Vitamin B12 Connection: A Risk Worth Monitoring

One genuine concern associated with long-term metformin use is reduced vitamin B12 levels.

Vitamin B12 is essential for healthy nerve function, red blood cell production, and DNA synthesis. Metformin can interfere with vitamin B12 absorption in some people, particularly with longer treatment duration or higher doses.

Over time, this may lead to vitamin B12 deficiency.

Why does vitamin B12 deficiency matter?

A deficiency can cause several symptoms, including:

• Tiredness and weakness
• Numbness or tingling in the hands and feet
• Balance difficulties
• Memory or concentration problems
• Certain types of anemia

The connection with nerve health is particularly important for people with diabetes. Vitamin B12 deficiency can produce nerve symptoms that may be confused with diabetic peripheral neuropathy.

Should everyone taking metformin have a B12 test?

Not everyone needs testing at the same interval. However, healthcare professionals may recommend checking vitamin B12 levels in people taking metformin who develop anemia, unexplained fatigue, or new nerve symptoms.

Periodic assessment may also be appropriate for people with additional risk factors for deficiency or those receiving long-term treatment.

If a deficiency is identified, a healthcare professional can recommend an appropriate supplement or other treatment.

Metformin Beyond Type 2 Diabetes: What About Prediabetes and PCOS?

Metformin is best known as a treatment for type 2 diabetes, but it also has uses in certain other metabolic conditions.

Metformin and diabetes prevention

The Diabetes Prevention Program (DPP), a major clinical study, examined whether lifestyle changes and metformin could delay the development of type 2 diabetes in people at high risk.

The original study found that metformin reduced the development of diabetes by about 31% over approximately three years compared with placebo. Intensive lifestyle intervention produced an even greater reduction.

Long-term follow-up has continued to show that the benefits of diabetes prevention can persist, although the size of the effect varies across populations.

Metformin may be considered for selected people with prediabetes, particularly those with higher-risk characteristics. It is not automatically recommended for everyone with elevated blood sugar.

Metformin and polycystic ovary syndrome (PCOS)

PCOS is a hormonal and metabolic condition that can affect menstrual cycles, ovulation, and fertility. Insulin resistance is common among people with PCOS, although it is not present in every case.

Metformin may help improve insulin-related metabolic measures in some people with PCOS. It can also support menstrual regularity in certain patients.

However, it is not a fertility treatment for everyone with PCOS, and its effect on ovulation and pregnancy outcomes varies. Other treatments may be more appropriate depending on the individual’s symptoms and reproductive goals.

Treatment should follow an individualized plan developed with a qualified healthcare professional.

Why Is Metformin Still So Widely Used?

Newer diabetes medicines have expanded the treatment options available to patients. Some can provide additional benefits for people with cardiovascular disease, heart failure, or chronic kidney disease.

However, metformin remains an important option because of several practical advantages:

• Established clinical experience: It has been studied and prescribed for decades.
• Effective blood sugar control: It can meaningfully reduce elevated blood glucose and HbA1c.
• Low hypoglycemia risk when used alone: It does not directly stimulate insulin release.
• Generally weight-neutral: It is not typically associated with medication-related weight gain.
• Affordable and widely available: Generic versions are available in many countries.
• Flexible treatment options: It can be used alone or alongside other diabetes medications when appropriate.

Metformin is not necessarily the best first choice for every person. Current treatment decisions also consider cardiovascular health, kidney function, weight-management goals, other medical conditions, and patient preferences.

Who Should Be Careful When Taking Metformin?

Metformin is not suitable for everyone. A healthcare professional should review a person’s medical history before prescribing it.

Particular care may be needed in people with:

• Significantly reduced kidney function
• Severe liver disease
• A history of metabolic acidosis
• Conditions associated with poor oxygen delivery or serious circulation problems
• Heavy alcohol use
• Acute illnesses involving severe dehydration or reduced food and fluid intake

Doctors may also recommend temporarily withholding metformin in certain situations, such as some procedures involving iodinated contrast material, depending on kidney function and other risk factors.

Patients should ask their healthcare team what to do during vomiting, diarrhea, fever, or other illnesses that may cause dehydration. They should not independently change their medication schedule.

The Bottom Line: Metformin Is Useful, but It Still Requires Monitoring

Metformin is neither a dangerous drug that everyone should avoid nor a medication without risks. It remains a well-established treatment for type 2 diabetes, with additional uses in selected people with prediabetes and PCOS.

Its most important precautions involve kidney function, the rare risk of lactic acidosis, digestive side effects, and possible vitamin B12 deficiency with long-term use.

For many patients, the benefits outweigh the risks when the medication is prescribed appropriately and monitored over time.

The best approach is to understand how metformin works, attend recommended follow-up appointments, and discuss any new symptoms or concerns with a healthcare professional. Online warnings should never be a reason to stop a prescribed diabetes medication without medical guidance.

Medical disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Metformin is a prescription medication. Decisions about starting, changing, or stopping treatment should always be made with a qualified healthcare professional.

References & Clinical Resources

• American Diabetes Association (ADA): Access the comprehensive Standards of Care in Diabetes guidelines covering pharmacologic approaches to glycemic treatment and prevention via the ADA Standards of Care Portal.
• The New England Journal of Medicine (NEJM): Review the original landmark findings of the Diabetes Prevention Program (DPP) Research Group detailing long-term reduction in the incidence of type 2 diabetes at the NEJM Archive.
• Endocrine Reviews: Explore peer-reviewed data on the molecular mechanisms of metformin action, mitochondrial Complex I inhibition, and AMPK activation through the Endocrine Society Research Portal.
• International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS): Read clinical practice recommendations on insulin sensitizers, ovulatory restoration, and metabolic outcomes from the Monash University PCOS Guidelines Hub.

Video Resource

Metformin Is One Of The Most Prescribed — And Most Misunderstood — Medications In Modern Medicine | Dr. Arti Thangudu, Endocrinologist

In this clinical breakdown, board-certified endocrinologist Dr. Arti Thangudu addresses viral misinformation, explains renal contraindications, and details the landmark DPP trials supporting metformin’s 60-year safety profile.